NZ2 Stock Overview
HealthBeacon plc, a digital therapeutics company, develops products for managing injectable medications for patients in the home in Europe, the United States, and Ireland. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
HealthBeacon plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.37 |
| 52 Week High | €2.36 |
| 52 Week Low | €0.57 |
| Beta | 1.22 |
| 11 Month Change | 0% |
| 3 Month Change | -6.16% |
| 1 Year Change | -43.85% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -77.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| NZ2 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.5% | 0.2% |
| 1Y | -43.9% | -6.8% | 8.5% |
Return vs Industry: NZ2 underperformed the German Medical Equipment industry which returned 9.8% over the past year.
Return vs Market: NZ2 underperformed the German Market which returned 9.5% over the past year.
Price Volatility
| NZ2 volatility | |
|---|---|
| NZ2 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: NZ2 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NZ2's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 70 | n/a | www.healthbeacon.com |
HealthBeacon plc, a digital therapeutics company, develops products for managing injectable medications for patients in the home in Europe, the United States, and Ireland. Its injection care management system tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence driven data analytics. The company provides HB Wave that notifies the patient and clinician when prescription refills are required and records visual images of pill containers to measure levels of medication adherence; HB Smart Scale which enables patients to add weight monitoring to injection care management system; and Global Patient Safety Platform, a proprietary software platform that help clinicians to prescribe medication to patients.
HealthBeacon plc Fundamentals Summary
| NZ2 fundamental statistics | |
|---|---|
| Market cap | €1.19m |
| Earnings (TTM) | -€14.11m |
| Revenue (TTM) | €2.24m |
0.5x
P/S Ratio-0.1x
P/E RatioIs NZ2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NZ2 income statement (TTM) | |
|---|---|
| Revenue | €2.24m |
| Cost of Revenue | €1.62m |
| Gross Profit | €627.00k |
| Other Expenses | €14.74m |
| Earnings | -€14.11m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.83 |
| Gross Margin | 27.94% |
| Net Profit Margin | -628.88% |
| Debt/Equity Ratio | 0% |
How did NZ2 perform over the long term?
See historical performance and comparison